Navigation Links
LIQUENT Announces XEVMPD Educational Series and Data Assessment Tool
Date:1/10/2012

HORSHAM, Pa., Jan. 10, 2012 /PRNewswire/ -- LIQUENT, Inc. the global leader in regulatory information management solutions and services, is pleased to announce LIQUENT's XEVMPD Educational Series and Data Assessment tool. Both are designed to assist in complying with the July 2012 deadline for submitting product information in eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) format. 

LIQUENT's XEVMPD Educational Series is designed to educate internal personnel about the requirements for XEVMPD.  The sessions consist of five recorded modules, for a total of four hours of training, focused on areas such as the understanding of why EMA is requiring XEVMPD, recent announcements and timelines, and requirements for authorized products, approved substances, and development substances and products. 

The XEVMPD Data Assessment tool will assist organizations in determining what data is needed for compliance and where the data is currently managed or tracked within the organization. 

"Companies are facing an unprecedented timeline for compliance," said Sarah Powell, Executive Director of Regulatory Affairs and Writing Services. "The LIQUENT XEVMPD Educational Series and XEVMPD Data Assessment tool provide an opportunity for companies to get a jump start on preparing their organizations, by ensuring employees are educated about the requirements and providing a clear understanding of the data needs." 

Successful transition to comply with the new XEVMPD requirements will mandate companies to evaluate standards, processes, technology, and organizational needs. LIQUENT's educational and solution offerings will support companies as they make necessary assessments.

For more information, Please contact info@liquent.com.

About LIQUENT, Inc.

LIQUENT provides technology and outsourcing solutions focused around regulatory submission preparation and tasks, dossier planning, eCTD to CTD publishing and registration tracking capabilities.  LIQUENT is the premier provider of a scalable, regulatory information management platform and associated regulatory & clinical services that can be leveraged throughout a client organization.

Contact:
Julie Burgess
Manager, Strategic Marketing
215-328-4513
Julie.burgess@liquent.com

 

 


'/>"/>
SOURCE LIQUENT, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients
2. BNA Books Announces the Publication of the 2011 Cumulative Supplement to "Pharmaceutical Law: Regulation of Research, Development, and Marketing"
3. NewCardio Announces Changes in Board of Directors and Executive Management
4. RSB Spine, LLC, Announces United States Patent Allowance
5. Hill-Rom Announces Preliminary Fiscal First Quarter Financial Results; Updates 2012 Financial Outlook
6. SequelMed Announces ANSI 5010 Upgrade for Its Users
7. Fembody™ Nutrition Announces Paula Abdul as Spokeswoman
8. ShangPharma Announces Opening of New Facility to Support Lillys Pipeline
9. Elsevier Announces Two Tetrahedron Symposia for 2012
10. Volcano Corporation Announces Preliminary Fourth Quarter 2011 Revenues
11. Hanger Orthopedic Group, Inc. Announces Fourth Quarter 2011 Earnings Release Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)... BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital in ... (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, ... uses UVC light energy to kill deadly pathogens such as C. diff , MRSA, ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics ... Dallas, Texas , has received notice from ... National Institutes of Health (NIH) that it has been ... grant totaling over $650,000 in 2017 with an additional ... CerSci,s Investigational New Drug application of their lead non-opioid ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... , ... Maury Regional Health has announced a large-scale adoption of AccuVein vein ... Maury Regional Medical Center is making vein visualization part of their standard of care. ... more importantly, helps our staff members locate a vein that will provide good access ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD ... ultimately, a cure. , The grants are awarded through a competitive application process ... a wide array of backgrounds and expertise in all areas relevant to PD research. ...
(Date:8/16/2017)... Sacramento, CA (PRWEB) , ... August 16, 2017 ... ... ($10.99, paperback, 9781498499613; $5.99, eBook, 9781498499620    ) shares that during the time of a ... as reminding Strawn of God's love, and all the many ways God shows ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... ... pain afflicting 8 of 10 Americans at some point in their lives, some of us ... equally vexing condition stems from a variety of causes that can be effectively targeted by ... president of Atlantic Spine Center. , Nestled between your neck and lower back, the ...
Breaking Medicine News(10 mins):